Avita Medical Ltd (RCEL)
Healthcare
Medical Devices
4.40 $
-2.0%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Avita Medical Ltd (RCEL)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 98.4% of the shares are freely tradable; institutional investors hold 17.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
17.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
1.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
98.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
10.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
31Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Group Inc | 4.69 | 1,444,579 | +5.8 | 12/31/2025 |
| Vanguard Capital Management, LLC | 4.34 | 1,335,152 | +0.0 | 03/31/2026 |
| BlackRock Inc | 3.68 | 1,133,126 | +4.9 | 03/31/2026 |
| Geode Capital Management, LLC | 1.76 | 542,974 | +13.3 | 03/31/2026 |
| State Street Corp | 1.39 | 429,022 | +2.6 | 03/31/2026 |
| Vanguard Fiduciary Trust Co | 0.63 | 193,436 | +0.0 | 03/31/2026 |
| Northern Trust Corp | 0.60 | 183,181 | +12.1 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 3.11 | 958,401 | +0.0 | 04/30/2026 |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.11 | 342,277 | +0.0 | 04/30/2026 |
| iShares Russell 2000 ETF | 1.05 | 322,866 | +0.9 | 05/29/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.